Shortened Course of Radiation Therapy After Trans-oral Robotic Surgery in Patients With HPV-Mediated Oropharyngeal Squamous Cell Carcinoma.

The goal of this study is to evaluate if a shorter course of therapy can improve the quality of life in patients receiving radiation therapy after trans-oral robotic surgery.

Trial Details

NCT ID
NCT07044635
Phase
PHASE2
Sponsor
University of Utah
Status
RECRUITING
Cancer Type
Head and Neck Cancer
Interventions
  • Radiation Therapy
Locations (sample)
  • Salt Lake City, Utah, United States|40.76078,-111.89105

Key Eligibility Criteria

  • Participant aged ≥ 18 years.
  • Diagnosis of oropharyngeal squamous cell carcinoma.
  • Eligible to receive transoral robotic surgery.
  • If status is known, p16 positivity or HPV positivity by in situ hybridization on pathological sampling of lymph node or primary oropharyngeal tumor…

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Head and Neck Cancer Trials on Trialify →